Preterm delivery risk in women initiating antiretroviral therapy to prevent HIV mother-to-child transmission

Premature Delivery in HIV-Infected Women Starting Protease Inhibitor Therapy During Pregnancy: Role of the Ritonavir Boost?

(2012) Jeanne Sibiude et al.   CLINICAL INFECTIOUS DISEASES

Highly Active Antiretroviral Therapy and Adverse Birth Outcomes Among HIV-Infected Women in Botswana

(2012) J. Y. Chen et al.   JOURNAL OF INFECTIOUS DISEASES

Increased Risk of Preterm Delivery Among HIV-Infected Women Randomized to Protease Versus Nucleoside Reverse Transcriptase Inhibitor-Based HAART During Pregnancy

(2011) Kathleen M. Powis et al.   JOURNAL OF INFECTIOUS DISEASES

Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial

(2011)   LANCET INFECTIOUS DISEASES

Increased rate of prematurity associated with antenatal antiretroviral therapy in a German/Austrian cohort of HIV-1-infected women

(2010) I Grosch-Woerner et al.   HIV MEDICINE

British HIV Association and Children's HIV Association guidelines for the management of HIV infection in pregnant women 2008

(2008) A de Ruiter et al.   HIV MEDICINE

Pregnancy outcome in women infected with HIV-1 receiving combination antiretroviral therapy before versus after conception

(2008) E S Machado et al.   SEXUALLY TRANSMITTED INFECTIONS